The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 06, 2018
Filed:
Aug. 01, 2016
Applicant:
Biomarin Pharmaceutical Inc., Novato, CA (US);
Inventors:
Sherry Bullens, Novato, CA (US);
Stuart Bunting, Novato, CA (US);
Tianwei Chou, Novato, CA (US);
Augustus O. Okhamafe, Concord, CA (US);
Christopher P. Price, Aachen, DE;
Daniel J. Wendt, Novato, CA (US);
Clarence Yap, Novato, CA (US);
Assignee:
BioMarin Pharmaceutical Inc., Novato, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61K 9/19 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/18 (2017.01); A61K 47/10 (2017.01); A61K 9/00 (2006.01); A61K 38/17 (2006.01);
U.S. Cl.
CPC ...
A61K 38/2242 (2013.01); A61K 9/0019 (2013.01); A61K 9/19 (2013.01); A61K 38/1709 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01);
Abstract
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.